Abstract PS1-11-28: Prognostic impact of type and location of germline BRCA2 pathogenic or likely pathogenic variants in patients with HR+/HER2- advanced breast cancer: results from the multicenter real-world PAMBRACA study
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: E. Zattarin, E. Tenedini, A. Marra, A. Palazzo, G. Griguolo, C. Vernieri, J. Etessami, L. Pontolillo, G. Landa, A. Daneri, M. De Monte, R. Cuoghi Costantini, O. Ponzoni, M. Razeti, C. Sposetti, E. Barbieri, M. Manni, L. Cortesi, G. Curigliano, E. Bria, V. Guarneri, M. Dominici, M. Lambertini, A. Toss
Institutions: University of Modena and Reggio Emilia, European Institute of Oncology, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, University of Padua, University of Milan, Ospedale Policlinico San Martino, Harvard University, Dana-Farber Cancer Institute, Azienda Ospedaliero-Universitaria di Modena, University of Genoa
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129448966
Cites:
Cited by:
Related to:
